Antibodies to CD36, a platelet glycoprotein, are associated with thrombosis, and anti-CD36 is highly prevalent in patients with aPL and with a trend to being more common in patients with recurrent thrombosis [49–51]. This evidence concerns the gene CD36 and Venous thrombosis.